Bernadette Van Roy
University of Antwerp
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernadette Van Roy.
Nature Genetics | 1993
Kristel De Boulle; Annemieke J. M. H. Verkerk; Edwin Reyniers; Lieve Vits; Jan Hendrickx; Bernadette Van Roy; Feikje Van Den Bos; Esther de Graaff; Ben A. Oostra; Patrick J. Willems
The vast majority of patients with fragile X syndrome show a folate–sensitive fragile site at Xq27.3 (FRAXA) at the cytogenetic level, and both amplification of the (CGG)n repeat and hypermethylation of the CpG island in the 5′ fragile X gene (FMR–1) at the molecular level. We have studied the FMR–1 gene of a patient with the fragile X phenotype but without cytogenetic expression of FRAXA, a (CGG)n repeat of normal length and an unmethylated CpG island. We find a single point mutation in FMR–1 resulting in an Ne367Asn substitution. This de novo mutation is absent in the patients family and in 130 control X chromosomes, suggesting that the mutation causes the clinical abnormalities. Our results suggest that mutations in FMR–1 are directly responsible for fragile X syndrome, irrespective of possible secondary effects caused by FRAXA
Human Genetics | 1996
Joke Beuten; Raoul C. M. Hennekam; Bernadette Van Roy; Kathelijne Mangelschots; James S. Sutcliffe; Dicky Halley; Frederic A. M. Hennekam; Arthur L. Beaudet; Patrick J. Willems
Angelman syndrome (AS) is characterized by severe mental retardation, absent speech, puppet-like movements, inappropriate laughter, epilepsy, and abnormal electroencephalogram. The majority of AS patients (≈ 65%) have a maternal deficiency within chromosomal region 15q11–q13, caused by maternal deletion or paternal uniparental disomy (UPD). Approximately 35% of AS patients exhibit neither detectable deletion nor UPD, but a subset of these patients have abnormal methylation at several loci in the 15q11–q13 interval. We describe here three patients with Angelman syndrome belonging to an extended inbred family. High resolution chromosome analysis combined with DNA analysis using 14 marker loci from the 15q11-q13 region failed to detect a deletion in any of the three patients. Paternal UPD of chromosome 15 was detected in one case, while the other two patients have abnormal methylation atD15S9, D15S63, andSNRPN. Although the three patients are distantly related, the chromosome 15q11-q13 haplotypes are different, suggesting that independent mutations gave rise to AS in this family.
Human Genetics | 1992
Kathelijne Mangelschots; Bernadette Van Roy; Franki Speleman; Nadine Van Roy; J. Gheuens; Joke Beuten; Herman Willekens; Jan E. Dumon; Berten Ceulemans; Patrick J. Willems
SummaryWe describe two female siblings with similar clinical features consisting of hydrocephalus, scaphocephaly, hypotonia, mongoloid eye slant, blepharophimosis, micrognathia, supernumerary mouth frenula and mental retardation. Routine cytogenetic studies in the elder patient did not reveal any abnormality, and initially it was assumed that the syndrome had an autosomal recessive inheritance. However, a slightly larger chromosome 13 was seen in routine G-banded metaphases of the mother and the youngest of the two siblings. A shorter chromosome 15 was detected in the mother only. High resolution banding showed that the abnormal chromosome 13 contained an extra G-positive band at 13q12. The short chromosome 15 in the mother appeared to have a deletion of band q12. Fluorescence in situ hybridization using DNA markers specific to chromosomes 13 and 15 unequivocally showed that the mother was a carrier of a balanced reciprocal translocation t(13;15)(q12;q13), whereas the youngest siblings karyotype was 46,XX,-13,+der(15)t(13;15)(q12;q13)mat, resulting in partial monosomy 13pter→q12 and partial trisomy 15pter→q13. The proband is thus trisomie for the critical region responsible for Prader-Willi syndrome and Angelman syndrome; this was confirmed by DNA analysis demonstrating one paternal and two maternal alleles from multiallelic marker loci mapping to 15q11-q13. This report illustrates the sensitivity and specificity offered by fluorescence in situ hybridization and its usefulness in the diagnosis and delineation of subtle chromosomal rearrangements.
Nature Genetics | 1993
Edwin Reyniers; Lieve Vits; Kristel De Boulle; Bernadette Van Roy; Désirée van Velzen; Esther de Graaff; Annemieke J. M. H. Verkerk; Hugo Z.J. Jorens; John K. Darby; Ben A. Oostra; Patrick J. Willems
Human Molecular Genetics | 1992
Patrick J. Willems; Bernadette Van Roy; Kristel De Boulle; Lieve Vits; Edwin Reyniers; Olivia Beck; Jan E. Dumon; Annemieke J. M. H. Verkerk; Ben A. Oostra
Journal of The American Academy of Dermatology | 1994
Julien Lambert; Patrick J. Willems; Roger Abs; Bernadette Van Roy
American Journal of Medical Genetics | 1993
Patrick J. Willems; Bernadette Van Roy; Wim J. Kleijer; Magna Van der Kraan; Jean-Jacques Martin
American Journal of Medical Genetics | 1993
Fabienne Marchau; Bernadette Van Roy; Paul M. Parizel; Julien Lambert; Ilse De Canck; Jules G. Leroy; Carine M. Gevaert; Patrick J. Willems; Jan E. Dumon
American Journal of Medical Genetics | 1990
Bernadette Van Roy; Patrick J. Willems; Lieve Vits; Berten Ceulemans; Paul Coucke; Bart J. Van der Auwera; Jacques A. G. Lormans; Jan E. Dumon
American Journal of Medical Genetics | 2005
Piet Stinissen; Bernadette Van Roy; Guy Van Camp; Hubert Backhovens; P. Partoens; Anita Wehnert; Heidi Verniers; Jan E. Dumon; Antoon Vandenberghe; Christine Van Broeckhoven